4-99887337-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021970.4(LAMTOR3):āc.62C>Gā(p.Ala21Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000847 in 1,535,682 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 0.0000087 ( 0 hom. )
Consequence
LAMTOR3
NM_021970.4 missense
NM_021970.4 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 8.99
Genes affected
LAMTOR3 (HGNC:15606): (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3) This gene encodes a scaffold protein that functions in the extracellular signal-regulated kinase (ERK) cascade. The protein is localized to late endosomes by the mitogen-activated protein-binding protein-interacting protein, and binds specifically to MAP kinase kinase MAP2K1/MEK1, MAP kinase MAPK3/ERK1, and MAP kinase MAPK1/ERK2. Studies of the orthologous gene in mouse indicate that it regulates late endosomal traffic and cell proliferation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. A pseudogene of this gene is located on the long arm of chromosome 13. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMTOR3 | NM_021970.4 | c.62C>G | p.Ala21Gly | missense_variant | 4/7 | ENST00000499666.7 | NP_068805.1 | |
LAMTOR3 | NM_001243736.1 | c.62C>G | p.Ala21Gly | missense_variant | 4/7 | NP_001230665.1 | ||
LAMTOR3 | NR_024170.1 | n.265C>G | non_coding_transcript_exon_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMTOR3 | ENST00000499666.7 | c.62C>G | p.Ala21Gly | missense_variant | 4/7 | 1 | NM_021970.4 | ENSP00000424183.1 | ||
LAMTOR3 | ENST00000515100.1 | n.147C>G | non_coding_transcript_exon_variant | 3/6 | 1 | |||||
LAMTOR3 | ENST00000226522.8 | c.62C>G | p.Ala21Gly | missense_variant | 4/7 | 3 | ENSP00000226522.8 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151850Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151850
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000503 AC: 11AN: 218890Hom.: 0 AF XY: 0.0000586 AC XY: 7AN XY: 119476
GnomAD3 exomes
AF:
AC:
11
AN:
218890
Hom.:
AF XY:
AC XY:
7
AN XY:
119476
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000867 AC: 12AN: 1383832Hom.: 0 Cov.: 22 AF XY: 0.0000116 AC XY: 8AN XY: 688068
GnomAD4 exome
AF:
AC:
12
AN:
1383832
Hom.:
Cov.:
22
AF XY:
AC XY:
8
AN XY:
688068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151850Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74176
GnomAD4 genome
AF:
AC:
1
AN:
151850
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74176
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.62C>G (p.A21G) alteration is located in exon 4 (coding exon 3) of the LAMTOR3 gene. This alteration results from a C to G substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at